Interactions between oxidative stress, lipid profile and antioxidants in breast cancer: a case control study RK Gupta, AK Patel, R Kumari, S Chugh, C Shrivastav, S Mehra, ... Asian Pacific Journal of Cancer Prevention 13 (12), 6295-6298, 2012 | 118 | 2012 |
HDAC5, a key component in temporal regulation of p53-mediated transactivation in response to genotoxic stress N Sen, R Kumari, MI Singh, S Das Molecular cell 52 (3), 406-420, 2013 | 60 | 2013 |
Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis R Kumari, RS Deshmukh, S Das Nature communications 10 (1), 4255, 2019 | 47 | 2019 |
p53 regulation upon genotoxic stress: intricacies and complexities R Kumari, S Kohli, S Das Molecular & cellular oncology 1 (3), e969653, 2014 | 47 | 2014 |
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism K Ueda, R Kumari, E Schwenger, JC Wheat, O Bohorquez, ... Cancer Cell 39 (4), 529-547. e7, 2021 | 27 | 2021 |
Tumour suppressor p53: understanding the molecular mechanisms inherent to cancer R Kumari, N Sen, S Das Current Science, 786-794, 2014 | 14 | 2014 |
An iron rheostat controls hematopoietic stem cell fate YR Kao, J Chen, R Kumari, A Ng, A Zintiridou, M Tatiparthy, Y Ma, ... Cell Stem Cell 31 (3), 378-397. e12, 2024 | 11 | 2024 |
Cytoplasmic labile iron accumulates in aging stem cells perturbing a key rheostat for identity control YR Kao, J Chen, R Kumari, M Tatiparthy, Y Ma, MM Aivalioti, A Zintiridou, ... Blood 138, 3282, 2021 | 5 | 2021 |
Pharmacological restriction of genomic binding sites redirects PU. 1 pioneer transcription factor activity SJ Taylor, J Stauber, O Bohorquez, G Tatsumi, R Kumari, J Chakraborty, ... Nature Genetics 56 (10), 2213-2227, 2024 | 4 | 2024 |
Fueling clonal dominance through TRAFficking of NF-κB signaling K Ueda, R Kumari, U Steidl Nature Immunology 21 (5), 489-490, 2020 | 1 | 2020 |
2003–MDMX ACTS AS A PERVASIVE PRELEUKEMIC-TO-ACUTE MYELOID LEUKEMIA SWITCH MECHANISM K Ueda, R Kumari, E Schwenger, J Wheat, O Bohorquez, ... Experimental Hematology 88, S27-S28, 2020 | | 2020 |
Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis S Das, R Kumari, RS Deshmukh Springer Nature Limited, 2019 | | 2019 |
Metformin-induced activation of caspase-10 inhibits lung adenocarcinoma progression and metastasis R Kumari, S Das Annals of Oncology 28, x139, 2017 | | 2017 |
Caspase-10 suppresses tumorigenesis by targeting ATP-citrate lyase R Kumari, S Das Cancer Research 77 (13_Supplement), 1543-1543, 2017 | | 2017 |
Differentiation Inducing Factor-1 Represses c-Myc and VEGF Expression in Myeloma Cells R Kumari, K Rehan, A Sharma International Journal of Hematology and Oncology 34 (1), 189-198, 2016 | | 2016 |